206 related articles for article (PubMed ID: 34148063)
1. Loss of expression of YAP1 C-terminus as an ancillary marker for epithelioid hemangioendothelioma variant with YAP1-TFE3 fusion and other YAP1-related vascular neoplasms.
Anderson WJ; Fletcher CDM; Hornick JL
Mod Pathol; 2021 Nov; 34(11):2036-2042. PubMed ID: 34148063
[TBL] [Abstract][Full Text] [Related]
2. Cytologic features of hepatic YAP1-TFE3 rearranged epithelioid hemangioendothelioma.
Bourgeau M; Martinez A; Deeb KK; Reid MD; Lewis M; Point du Jour KS; Lai J; Shi Q
Diagn Cytopathol; 2021 Dec; 49(12):E447-E452. PubMed ID: 34411462
[TBL] [Abstract][Full Text] [Related]
3. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.
Antonescu CR; Le Loarer F; Mosquera JM; Sboner A; Zhang L; Chen CL; Chen HW; Pathan N; Krausz T; Dickson BC; Weinreb I; Rubin MA; Hameed M; Fletcher CD
Genes Chromosomes Cancer; 2013 Aug; 52(8):775-84. PubMed ID: 23737213
[TBL] [Abstract][Full Text] [Related]
4. Nuclear Expression of CAMTA1 Distinguishes Epithelioid Hemangioendothelioma From Histologic Mimics.
Doyle LA; Fletcher CD; Hornick JL
Am J Surg Pathol; 2016 Jan; 40(1):94-102. PubMed ID: 26414223
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants.
Patel NR; Salim AA; Sayeed H; Sarabia SF; Hollingsworth F; Warren M; Jakacky J; Tanas M; Oliveira AM; Rubin BP; Lazar AJ; López-Terrada D; Wang WL
Histopathology; 2015 Nov; 67(5):699-708. PubMed ID: 25817592
[TBL] [Abstract][Full Text] [Related]
6. Epithelioid hemangioendothelioma (EHE) with WWTR1::TFE3 gene fusion, a novel fusion variant.
Li S; Dermawan JK; Seavey CN; Ma S; Antonescu CR; Rubin BP
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23226. PubMed ID: 38380774
[TBL] [Abstract][Full Text] [Related]
7. YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases.
Dermawan JK; Azzato EM; Billings SD; Fritchie KJ; Aubert S; Bahrami A; Barisella M; Baumhoer D; Blum V; Bode B; Aesif SW; Bovée JVMG; Dickson BC; van den Hout M; Lucas DR; Moch H; Oaxaca G; Righi A; Sciot R; Sumathi V; Yoshida A; Rubin BP
Mod Pathol; 2021 Dec; 34(12):2211-2221. PubMed ID: 34381186
[TBL] [Abstract][Full Text] [Related]
8. Hepatic
Lotfalla MM; Folpe AL; Fritchie KJ; Greipp PT; Galliano GG; Halling KC; Mounajjed T; Torres-Mora J; Graham RP
Case Rep Gastrointest Med; 2019; 2019():7530845. PubMed ID: 31341686
[TBL] [Abstract][Full Text] [Related]
9. TFE3 rearranged epithelioid hemangioendothelioma of bone: A clinicopathological, immunohistochemical and molecular study of two cases.
Zhang HZ; Dong L; Wang SY; Yang XQ
Ann Diagn Pathol; 2020 Jun; 46():151487. PubMed ID: 32151991
[TBL] [Abstract][Full Text] [Related]
10. Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets.
Rosenbaum E; Jadeja B; Xu B; Zhang L; Agaram NP; Travis W; Singer S; Tap WD; Antonescu CR
Mod Pathol; 2020 Apr; 33(4):591-602. PubMed ID: 31537895
[TBL] [Abstract][Full Text] [Related]
11. CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma.
Shibuya R; Matsuyama A; Shiba E; Harada H; Yabuki K; Hisaoka M
Histopathology; 2015 Dec; 67(6):827-35. PubMed ID: 25879300
[TBL] [Abstract][Full Text] [Related]
12. Recurrent YAP1 and MAML2 Gene Rearrangements in Retiform and Composite Hemangioendothelioma.
Antonescu CR; Dickson BC; Sung YS; Zhang L; Suurmeijer AJH; Stenzinger A; Mechtersheimer G; Fletcher CDM
Am J Surg Pathol; 2020 Dec; 44(12):1677-1684. PubMed ID: 32991341
[TBL] [Abstract][Full Text] [Related]
13. TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex.
Merritt N; Garcia K; Rajendran D; Lin ZY; Zhang X; Mitchell KA; Borcherding N; Fullenkamp C; Chimenti MS; Gingras AC; Harvey KF; Tanas MR
Elife; 2021 Apr; 10():. PubMed ID: 33913810
[TBL] [Abstract][Full Text] [Related]
14. CAMTA-1 Expression in 24 Cases of Hepatic Epithelioid Hemangioendothelioma in a Single Institute: Diagnostic Utility for Differential Diagnosis from Hepatic Angiosarcoma.
Jung H; Kim HN; Jang Y; Park CK; Ha SY
In Vivo; 2019; 33(6):2293-2297. PubMed ID: 31662570
[TBL] [Abstract][Full Text] [Related]
15. YAP1-TFE3 epithelioid hemangioendothelioma: a case without vasoformation and a new transcript variant.
Puls F; Niblett A; Clarke J; Kindblom LG; McCulloch T
Virchows Arch; 2015 Apr; 466(4):473-8. PubMed ID: 25680571
[TBL] [Abstract][Full Text] [Related]
16. [Epithelioid hemangioendothelioma with TFE3 translocation in soft tissue:a clinicopathological study].
Song QY; Zhu XM; Song GX; Li X; Fan QH; Zhang ZH; Gong QX
Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1151-1156. PubMed ID: 34619869
[No Abstract] [Full Text] [Related]
17. TFE3-rearranged hepatic epithelioid hemangioendothelioma-a case report with immunohistochemical and molecular study.
Kuo FY; Huang HY; Chen CL; Eng HL; Huang CC
APMIS; 2017 Sep; 125(9):849-853. PubMed ID: 28585251
[TBL] [Abstract][Full Text] [Related]
18. Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements.
Lee SJ; Yang WI; Chung WS; Kim SK
Oncotarget; 2016 Feb; 7(7):7480-8. PubMed ID: 26840265
[TBL] [Abstract][Full Text] [Related]
19. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.
Hung YP; Fletcher CD; Hornick JL
Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608
[TBL] [Abstract][Full Text] [Related]
20. Multicentric visceral epithelioid hemangioendothelioma, with extremity dermal deposits, unusual late recurrence on the nasal bridge, and TFE3 gene rearrangement.
Thway K; Mentzel T; Perrett CM; Calonje E
Hum Pathol; 2018 Feb; 72():153-159. PubMed ID: 28855107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
